Begin with the Exit in Mind

Mezzanine Opportunities

In addition to early and mid-stage ventures, Epic BioVentures will also seek mezzanine opportunities with revenue-stage medical technology companies, particularly those with exceptional valuations due to current market challenges. We see a tremendous opportunity in the current market to add value to multiple companies by merging complementary businesses.


Epic BioVentures aims to maximize the advantages associated with investing in challenging economic environments. These advantages include lower valuations and more aggressive protective provisions, which in the aggregate are designed to increase the potential upside and decrease the potential downside of making earlier-stage investments. Our target market is early and mid-stage companies that are committed to using every investment dollar to its maximum potential.